v3 Template
A
AnPac Bio-Medical Science Co., Ltd.
Healthcare/Biotechnology
~10 employees
Founded
--
Employees (Est.)
~10
1 leaders known
Total Funding
$13.2M
Funding Rounds
3
Last Funding
2023-04-06
About AnPac Bio-Medical Science Co., Ltd.
Anpac Bio, founded in 2010 by interdisciplinary scientists and experts in medicine, physics, biology, biochemistry, and nanotechnology, is a pioneer and leader in multi-cancer detection and an early developer of multi-level, multi-parameter cancer screening technology. The company focuses on breakthrough innovations using a multi-disciplinary approach combining nanotechnology, biophysical, and biomedical technologies to overcome challenges in early cancer screening. Anpac Bio conducts multi-cancer detection tests using its patented Cancer Differentiation Analysis (CDA) technology, accumulating over 300,000 test samples and data, with the mission of saving lives.
Products & Services
CDA Early Cancer Risk Assessment:A combination test using CDA and gene analysis for early cancer risk assessment.
APCS Pan-Cancer Screening:A comprehensive screening test using CDA and gene analysis for pan-cancer detection.
ADME Third Immune Defense Test:A test combining CDA and gene analysis focused on immune defense evaluation.
Specialties
Multi-cancer detection
Cancer Differentiation Analysis (CDA) technology
Early cancer screening
Nanotechnology
Biophysical and biomedical technologies
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 3000000 MR: - FA: 3.0 million FAN: 3000000 |
D: 2023-04-06 FD: 2023-04-06 |
1 investors |
| 2 |
RT: Private Placement T: - FT: Private Placement |
A: 5000000 MR: - FA: US$5 million FAN: 5000000 |
D: 2023-03-06 FD: 2023-03-06 |
1 investors |
| 3 |
RT: Equity Investment T: - FT: Equity Investment |
A: 5200000 MR: - FA: 5.2 million FAN: 5200000 |
D: 2023-01-25 FD: 2023-01-25 |
1 investors |
Registered Direct Offering
Latest
2023-04-06
$3.0M
1 investor (Pro only)
Private Placement
2023-03-06
$5.0M
Equity Investment
2023-01-25
$5.2M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
C
Chris Yu
Founder/Chairman
Recent News
AnPac Bio-Medical Science Co., Ltd. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- anpacbio.com
- Industries
- Healthcare/Biotechnology
- Company Size
- ~10 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro